Shakiba S, Freeman W R, Flores-Aguilar M, Munguia D, Tatebayashi M, Besen G, Amani R, Wiley C A, Vuong C, Aldern K A
Department of Ophthalmology, University of California, San Diego, La Jolla 92093, USA.
Antimicrob Agents Chemother. 1995 Jun;39(6):1383-5. doi: 10.1128/AAC.39.6.1383.
Acyclovir diphosphate dimyristoylglycerol (ACVDP-DG) is a lipid prodrug which is active against ACV-resistant strains of herpes simplex virus because of its intracellular metabolism to ACV monophosphate. In human cytomegalovirus (HCMV)-infected MRC-5 cells, ACVDP-DG was ninefold more active than ACV. When liposomal [8-3H]ACVDP-DG was injected intravitreally at the maximum nontoxic dose of 1 mumol in rabbits, the drug remained above its estimated 90% HCMV-inhibitory concentration for 18 days. Intravitreal ganciclovir persists above its 90% inhibitory concentration for only 1 to 2 days. ACVDP-DG may be useful as a local treatment for HCMV retinitis.
阿昔洛韦二磷酸二肉豆蔻酰甘油(ACVDP-DG)是一种脂质前药,由于其在细胞内代谢为阿昔洛韦单磷酸,因此对单纯疱疹病毒的阿昔洛韦耐药菌株具有活性。在人巨细胞病毒(HCMV)感染的MRC-5细胞中,ACVDP-DG的活性比阿昔洛韦高9倍。当以1 μmol的最大无毒剂量将脂质体[8-3H]ACVDP-DG玻璃体内注射到兔子体内时,该药物在18天内一直保持在其估计的90% HCMV抑制浓度以上。玻璃体内注射更昔洛韦仅在1至2天内保持在其90%抑制浓度以上。ACVDP-DG可能作为HCMV视网膜炎的局部治疗药物有用。